Literature DB >> 3935494

Treatment of gonorrhoea with cefotiam: activity in vitro and clinical results of a 1-gram single-dose regimen.

H C Korting, U Neubert.   

Abstract

Cefotiam is clearly more active against Neisseria gonorrhoeae in vitro than penicillin. This applies especially to strains producing beta-lactamase but also to those which do not. No strain requires more than 0.25 micrograms/ml for inhibition. 1 g of cefotiam dissolved in 3 ml of 1% lidocaine solution cures 90.0% of patients suffering from uncomplicated genital gonorrhoea if injected once intramuscularly. Tolerance of this regimen is very good, no major side-effect being found.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3935494     DOI: 10.1159/000249435

Source DB:  PubMed          Journal:  Dermatologica        ISSN: 0011-9075


  3 in total

1.  Plasmid content, serotypes, and antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Munich in 1987-88.

Authors:  D Abeck; A P Johnson; W Grimm; R Zaba; H C Korting
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

2.  Skin tissue fluid levels of cefotiam in healthy man following oral cefotiam hexetil.

Authors:  H C Korting; M Schäfer-Korting; F Kees; A Lukacs; H Grobecker
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteers.

Authors:  H C Korting; M Schäfer-Korting; L Maass; N Klesel; E Mutschler
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.